MedTrace Logo

SWiss Evaluation of Bioabsorbable Polymer-coated Everolimus-eluting Coronary sTent

NCT02150876 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1000

Last updated 2015-12-03

No results posted yet for this study

Summary

Bioresorbable polymer drug eluting stents (DES) are an indisputable improvement over first-generation DES with promising results on long-term adverse events. But the thicker polymer and/or strut may hinder its deliverability. Complex procedures challenge stent deliverability and stent delivery failure impacts clinical prognosis.

This registry aimed to assess the immediate performance of the third-generation Synergy everolimus-eluting stent (sEES) and its 12-month clinical follow-up in an all-comer population.

Conditions

Sponsors & Collaborators

  • University of Freiburg

    lead OTHER

Principal Investigators

  • Stéphane P Cook, MD · University of Freiburg

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-06-30
Primary Completion
2014-09-30
Completion
2014-09-30

Countries

  • Switzerland

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02150876 on ClinicalTrials.gov